Quest Diagnostics Debt to Equity Ratio 2010-2024 | DGX

Current and historical debt to equity ratio values for Quest Diagnostics (DGX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Quest Diagnostics debt/equity for the three months ending September 30, 2024 was 0.83.
Quest Diagnostics Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-09-30 $9.25B $6.84B 1.35
2024-06-30 $7.23B $6.66B 1.09
2024-03-31 $7.49B $6.47B 1.16
2023-12-31 $7.68B $6.34B 1.21
2023-09-30 $7.02B $6.46B 1.09
2023-06-30 $7.14B $6.29B 1.14
2023-03-31 $6.71B $6.09B 1.10
2022-12-31 $6.91B $5.93B 1.17
2022-09-30 $6.95B $6.27B 1.11
2022-06-30 $6.86B $6.45B 1.06
2022-03-31 $7.03B $6.42B 1.10
2021-12-31 $7.13B $6.48B 1.10
2021-09-30 $7.14B $6.43B 1.11
2021-06-30 $6.92B $5.94B 1.17
2021-03-31 $7.14B $6.79B 1.05
2020-12-31 $7.22B $6.81B 1.06
2020-09-30 $7.70B $6.45B 1.19
2020-06-30 $7.11B $5.88B 1.21
2020-03-31 $6.35B $5.70B 1.11
2019-12-31 $7.16B $5.69B 1.26
2019-09-30 $6.37B $5.65B 1.13
2019-06-30 $6.25B $5.51B 1.14
2019-03-31 $6.60B $5.34B 1.24
2018-12-31 $5.74B $5.27B 1.09
2018-09-30 $5.62B $5.37B 1.05
2018-06-30 $5.48B $5.26B 1.04
2018-03-31 $5.63B $5.07B 1.11
2017-12-31 $5.55B $4.96B 1.12
2017-09-30 $5.61B $4.83B 1.16
2017-06-30 $5.44B $4.73B 1.15
2017-03-31 $5.45B $4.66B 1.17
2016-12-31 $5.44B $4.66B 1.17
2016-09-30 $5.48B $4.69B 1.17
2016-06-30 $5.54B $4.57B 1.21
2016-03-31 $5.43B $4.67B 1.16
2015-12-31 $5.25B $4.71B 1.11
2015-09-30 $5.45B $4.62B 1.18
2015-06-30 $5.38B $4.34B 1.24
2015-03-31 $6.34B $4.27B 1.49
2014-12-31 $5.53B $4.33B 1.28
2014-09-30 $5.59B $4.21B 1.33
2014-06-30 $5.64B $4.12B 1.37
2014-03-31 $5.53B $4.02B 1.38
2013-12-31 $4.98B $3.97B 1.25
2013-09-30 $5.06B $3.87B 1.31
2013-06-30 $5.10B $3.94B 1.29
2013-03-31 $5.08B $4.23B 1.20
2012-12-31 $5.10B $4.19B 1.22
2012-09-30 $5.12B $4.20B 1.22
2012-06-30 $5.37B $4.02B 1.34
2012-03-31 $5.56B $3.90B 1.43
2011-12-31 $5.60B $3.72B 1.51
2011-09-30 $5.78B $3.55B 1.63
2011-06-30 $5.98B $3.45B 1.73
2011-03-31 $5.99B $3.24B 1.85
2010-12-31 $4.47B $4.05B 1.10
2010-09-30 $4.58B $3.88B 1.18
2010-06-30 $4.54B $3.95B 1.15
2010-03-31 $4.59B $3.93B 1.17
2009-12-31 $4.55B $4.01B 1.14
2009-09-30 $4.43B $3.94B 1.12
2009-06-30 $4.45B $3.77B 1.18
2009-03-31 $4.81B $3.53B 1.36
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $17.320B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.921B 12.66
DaVita (DVA) United States $12.060B 15.60
Encompass Health (EHC) United States $10.267B 24.21
Chemed (CHE) United States $8.277B 25.44
Elanco Animal Health (ELAN) United States $6.357B 14.29
RadNet (RDNT) United States $5.166B 122.54
Option Care Health (OPCH) United States $3.999B 18.95
Amedisys (AMED) United States $3.199B 22.78
Astrana Health (ASTH) United States $2.920B 41.31
LifeStance Health (LFST) United States $2.728B 0.00
Addus HomeCare (ADUS) United States $2.375B 27.86
U.S Physical Therapy (USPH) United States $1.464B 38.53
Pennant (PNTG) United States $1.004B 46.00
Aveanna Healthcare Holdings (AVAH) United States $0.929B 0.00
Atai Life Sciences (ATAI) Germany $0.198B 0.00
Daxor (DXR) United States $0.047B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.013B 0.00
Ontrak (OTRK) United States $0.007B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00